HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 133 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $168,000 | -78.8% | 12,500 | -64.3% | 0.16% | -67.9% |
Q2 2015 | $791,000 | +57.9% | 35,050 | 0.0% | 0.49% | +47.3% |
Q1 2015 | $501,000 | +72.8% | 35,050 | +16.6% | 0.33% | +114.1% |
Q4 2014 | $290,000 | -29.3% | 30,050 | -33.3% | 0.16% | -46.2% |
Q3 2014 | $410,000 | -17.0% | 45,050 | -10.0% | 0.29% | -5.5% |
Q2 2014 | $494,000 | -46.8% | 50,050 | -31.5% | 0.31% | -38.7% |
Q1 2014 | $928,000 | -4.7% | 73,050 | +12.4% | 0.50% | +6.6% |
Q4 2013 | $974,000 | +35.7% | 65,000 | 0.0% | 0.47% | +7.3% |
Q3 2013 | $718,000 | +20.5% | 65,000 | -13.3% | 0.44% | +3.5% |
Q2 2013 | $596,000 | – | 75,000 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |